<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Psychiatry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DE32C476-09A8-4BCA-A101-9312BFB03827"><gtr:id>DE32C476-09A8-4BCA-A101-9312BFB03827</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>Clive</gtr:otherNames><gtr:surname>Anthony</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A5BF706D-31D6-4E3C-ACAF-FA83648DE98B"><gtr:id>A5BF706D-31D6-4E3C-ACAF-FA83648DE98B</gtr:id><gtr:firstName>Kaare</gtr:firstName><gtr:surname>Fugleholm</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300456"><gtr:id>AE4C0434-3B65-4F0E-83EE-B3BAB556B75B</gtr:id><gtr:title>Hepatic amplification of the inflammatory response after CNS injury</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300456</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>295524</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Oxford Contrast ltd.</gtr:description><gtr:id>4C7534AC-EE5A-4C1E-8A6B-B994FE7C34E7</gtr:id><gtr:impact>The outputs have included publication listed in section 2.</gtr:impact><gtr:outcomeId>6848E28E0C6-1</gtr:outcomeId><gtr:partnerContribution>The construction of novel MRI-based contrast agentsReagents have been made available</gtr:partnerContribution><gtr:piContribution>The work generated under this grant has led to the formation of a spin-out company called Oxford Contrast.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Cardiovascular Medicine</gtr:department><gtr:description>Oxford Contrast ltd.</gtr:description><gtr:id>3994126A-495A-4580-8414-1E50B2F40215</gtr:id><gtr:impact>The outputs have included publication listed in section 2.</gtr:impact><gtr:outcomeId>6848E28E0C6-2</gtr:outcomeId><gtr:partnerContribution>The construction of novel MRI-based contrast agentsReagents have been made available</gtr:partnerContribution><gtr:piContribution>The work generated under this grant has led to the formation of a spin-out company called Oxford Contrast.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Training teachers in science</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>4479E24C-5B4E-4F6E-B2B3-6D2181EF71FD</gtr:id><gtr:impact>Dr. Anthony gives numerous talks in schools, and will continue to support and actively contribute to the 'brain train' initiative, which provides neuroscience training for schoolteachers.

We have provided summer work experience placements for schoolchildren, teachers, and visiting educators from abroad.</gtr:impact><gtr:outcomeId>B44FF505A4E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>236052</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DB57142F-1A07-4954-88F8-2C627C015D24</gtr:id><gtr:outcomeId>5D931BEB0200</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have described a novel imaging agent</gtr:description><gtr:grantRef>G0300456</gtr:grantRef><gtr:id>8ED7D6E8-1EFA-47B6-8BE9-D1465886AF6B</gtr:id><gtr:impact>Commercial in Confidence</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>0B2A8E8B44B</gtr:outcomeId><gtr:patentId>US2008311048</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Sugar-targeted contrast agents</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>DPFS awarded to Dr Nicola Sibson, Daniel Anthony, Ben Davis, and Robin Choudhury</gtr:description><gtr:id>007F5822-2A52-4D30-87C4-B62701EEA276</gtr:id><gtr:impact>This invention will lead to the earlier diagnosis of multiple sclerosis, and brain metastasis.</gtr:impact><gtr:outcomeId>22A8C768AC1</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>OxCon</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>For use in MRI experiments for molecular imaging</gtr:description><gtr:id>6DB1E3DB-6225-41F9-85DA-87C8660593CB</gtr:id><gtr:impact>High-profile publications</gtr:impact><gtr:outcomeId>710071DB9A5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Targeted contrast media</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Oxford Contrast</gtr:companyName><gtr:description>The company is seeking to produce targeted contrast agent for use in MRI and PET; http://www.oxfordcontrast.com/</gtr:description><gtr:id>02AC83B1-2D84-422C-879F-72E3624E6C69</gtr:id><gtr:impact>First round funding expected Jan 2010</gtr:impact><gtr:outcomeId>90376A2D9D6</gtr:outcomeId><gtr:yearCompanyFormed>2009</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>28EA1BC1-B53C-4F82-90E4-1240A9DED3C7</gtr:id><gtr:title>MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c25a6eecb7ba2c00df4be8e89b50aa9c"><gtr:id>c25a6eecb7ba2c00df4be8e89b50aa9c</gtr:id><gtr:otherNames>Broom KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>0E55ACA3896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>598CDB76-2481-496F-8C8F-916A8C0F896E</gtr:id><gtr:title>Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc117e727538516535f26bb466da33fc"><gtr:id>bc117e727538516535f26bb466da33fc</gtr:id><gtr:otherNames>Campbell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>79B50DE756F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>041326CD-03C2-46CA-A4AF-07DC5354E91F</gtr:id><gtr:title>Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7d6414b5561959e026a21adb7b56753"><gtr:id>f7d6414b5561959e026a21adb7b56753</gtr:id><gtr:otherNames>Jiang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>104E33DBAAA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0FBAF0C-ECBC-4A67-A8FC-A789BC378373</gtr:id><gtr:title>Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feb64d6405c8d7955872aa45e2535e08"><gtr:id>feb64d6405c8d7955872aa45e2535e08</gtr:id><gtr:otherNames>Stuckey DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>CF382356AD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB98F137-3EBF-4882-A2D4-AD58ED61525F</gtr:id><gtr:title>Overexpression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc117e727538516535f26bb466da33fc"><gtr:id>bc117e727538516535f26bb466da33fc</gtr:id><gtr:otherNames>Campbell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>196A9534807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70685A8C-2C7B-4E97-87D2-342D0C457C11</gtr:id><gtr:title>Acute astrocyte activation in brain detected by MRI: new insights into T(1) hypointensity.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73a32ab19c802a76108b0429c89ebb8d"><gtr:id>73a32ab19c802a76108b0429c89ebb8d</gtr:id><gtr:otherNames>Sibson NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>DF8FAD1F936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1312BF80-9D5F-47C8-8C7E-499FF5202127</gtr:id><gtr:title>In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa27aad6265160dc5178eb3e2ed5112e"><gtr:id>fa27aad6265160dc5178eb3e2ed5112e</gtr:id><gtr:otherNames>McAteer MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>37B1B99EA12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C2D4BBF-EB2E-4A36-957B-32EB58CC0B39</gtr:id><gtr:title>Loss of the atypical inflammatory response in juvenile and aged rats.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc117e727538516535f26bb466da33fc"><gtr:id>bc117e727538516535f26bb466da33fc</gtr:id><gtr:otherNames>Campbell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5CE9820BFE8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2FCB5F9-4BA2-4DA6-B2FC-EC3BA4E7681C</gtr:id><gtr:title>Liver Kupffer cells control the magnitude of the inflammatory response in the injured brain and spinal cord.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc117e727538516535f26bb466da33fc"><gtr:id>bc117e727538516535f26bb466da33fc</gtr:id><gtr:otherNames>Campbell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>54583F8C53A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C72D2D8E-088E-4CD5-97FE-47C18C2B680E</gtr:id><gtr:title>Hepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc117e727538516535f26bb466da33fc"><gtr:id>bc117e727538516535f26bb466da33fc</gtr:id><gtr:otherNames>Campbell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>289FE567A84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D2C6405-9294-4261-B003-DB30C7C4F693</gtr:id><gtr:title>Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc117e727538516535f26bb466da33fc"><gtr:id>bc117e727538516535f26bb466da33fc</gtr:id><gtr:otherNames>Campbell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>B437D66E57B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D696ED18-0E9D-4FD6-AFE7-FA9BDA297AD4</gtr:id><gtr:title>The role of hemorrhage following spinal-cord injury.</gtr:title><gtr:parentPublicationTitle>Brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/681e41b8438e67a8b3a6e3cc5efb7655"><gtr:id>681e41b8438e67a8b3a6e3cc5efb7655</gtr:id><gtr:otherNames>Losey P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8993</gtr:issn><gtr:outcomeId>pm_540e139e139193ecc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72F818A0-C18B-4F1D-826B-676DA7AA8906</gtr:id><gtr:title>Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29d27cae47ad7c9b05d907e07fa09734"><gtr:id>29d27cae47ad7c9b05d907e07fa09734</gtr:id><gtr:otherNames>Davis AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>B64FE7BBDDE</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300456</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>